MIRA INFORM REPORT

 

 

Report Date :

09.05.2012

 

IDENTIFICATION DETAILS

 

Name :

SOLITAIRE PHARMACIA PRIVATE LIMITED

 

 

Registered Office :

Plot No.73, Industrial Area, Phase – II, Chandigarh – 160002

 

 

Country :

India

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

07.08.2003

 

 

Com. Reg. No.:

53-026264

 

 

Capital Investment / Paid-up Capital :

Rs.0.890 Million

 

 

CIN No.:

[Company Identification No.]

U24232CH2003PTC026264

 

 

IEC No.:

2208003799

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

PTLS15553G

 

 

PAN No.:

[Permanent Account No.]

AAHCS5485R

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer and Exporter of Pharmaceutical Formulation-Finished Medicines.

 

 

No. of Employees :

100 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (46)

 

RATING

STATUS

PROPOSED CREDIT LINE

 

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

 

Maximum Credit Limit :

USD 35000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track. Trade relations are fair. Business is active. Payments are reported to be usually correct and as per commitments.

 

The Company can be considered normal for business dealings at usual trade terms and conditions.

 

 

NOTES:

 

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – September 30, 2011

 

Country Name

Previous Rating

(30.06.2011)

Current Rating

(30.09.2011)

India

A1

A1

 

 

 

 

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INFORMATION PARTED BY

 

Name :

Mr. Kuljender

Designation :

Accounts Manager

Contact No.:

91-172-4237709

Date :

19.04.2012

 

 

LOCATIONS

 

Registered Office :

Plot No.73, Industrial Area, Phase-II, Chandigarh-160002, India

Tel. No.:

91-172-4237704/ 09/ 4600087/ 88/ 5000477/ 5000478

Fax No.:

91-172-4600087/ 5000477/ 2653293

E-Mail :

radixbiotech@rediffmail.com

radixbiotech@yahoo.com

radixexports@rediffmail.com

avnish61@hotmail.com

khullar_rohitcs@yahoo.co.in

Website :

http://www.solitairepharmacia.com

Area :

1500 sq. ft.

Location :

Rented

 

 

Factory :

Plot No. 25, HPSIDC, Industrial Area, Extension 1, Baddi District Salan, Himachal Pradesh-173205, India

Location :

Owned

 

 

DIRECTORS

 

(AS ON 30.09.2011)

 

Name :

Mr. Sanjeev Kumar Sethi

Designation :

Managing Director

Address :

Flat No.503, GH – 30, Sector 20, Panchkula – 134108, Haryana, India

Date of Birth/Age :

21.09.1970

Date of Appointment :

01.07.2006

DIN No.:

00487430

Other Directorship :

 

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U24232CH1987PTC026264

SOLITAIRE PHARMACIA PRIVATE LIMITED

Managing director

1/7/2006

7/8/2003

-

Active

NO

2

U24232CH2004PTC027742

RADIX BIOTECH PRIVATE LIMITED

Director

17/12/2004

17/12/2004

-

Active

NO

3

U51909CH2008PTC031111

STERLING IMPORT AND EXPORT PRIVATE LIMITED

Director

29/02/2008

29/02/2008

19/07/2011

Active

YES

 

 

Name :

Mrs. Anita Sanjeev Sethi

Designation :

Director

Address :

Flat No.503, GH – 30, Sector 20, Panchkula – 134108, Haryana, India

Date of Birth/Age :

10.02.1978

Date of Appointment :

01.07.2006

DIN No.:

00487432

Other Directorship :

 

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Company Status

Defaulting status

1

U24232CH1987PTC026264

SOLITAIRE PHARMACIA PRIVATE LIMITED

Whole-time director

1/7/2006

7/8/2003

Active

NO

2

U24232CH2004PTC027742

RADIX BIOTECH PRIVATE LIMITED

Director

17/12/2004

17/12/2004

Active

NO

 

 

Name :

Mrs. Pushpa Gobind Ram Rani

Designation :

Director

Address :

H. No.503, GHS-30, Sector – 20, Panchkula, Haryana, India

Date of Birth/Age :

01.01.1954

Date of Appointment :

07.08.2003

DIN No.:

01381614

 

 

KEY EXECUTIVES

 

Name :

Mr. Kuljender

Designation :

Accounts Manager

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

(AS ON 30.09.2011)

 

Names of Shareholders

 

 

No. of Shares

 

 

 

Sanjeev Kumar Sethi

 

19934

Anita Sethi

 

23333

Pushpa Rani

 

3333

Anand Khosla

 

2400

Anand Khosla (HUF) through Karta Anand Khosla

 

40000

 

 

 

Total

 

 

89000

 

 

(AS ON 30.09.2011)

Equity Shares Break – up

 

Category

 

Percentage

 

 

 

Directors or relatives of directors

 

100.00

 

 

 

Total

 

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Exporter of Pharmaceutical Formulation-Finished Medicines.

 

 

Products :

·         Anti-Biotic Tablets

·         Hormonal Tablets

·         Psychotropic Tablets

·         Diabetic Tablets

·         Cardiac Tablets

·         Women and Child Care Drugs

·         Ortho-Care Drugs

·         Eye Drops

·         Ear Drops

·         Nasal Drops

·         Inject able Products

·         Day to Day Care Drugs 

·         Tablets, Syrups, Capsules and Injections

 

 

Exports :

 

Products :

·         Pharmaceutical Formulation

Countries :

·         Nepal

·         Ghana

 

 

Imports :

 

Products :

Raw Materials

Countries :

·         China

·         Italy

 

 

Terms :

 

Selling :

L/C and Advance

 

 

Purchasing :

L/C and Advance

 

 

GENERAL INFORMATION

 

Suppliers :

·         Aryata Reliabilitation Private Limited

·         Ansh Lab Chem

·         Ashirwad Medicose

·         B R Enterprises

·         Bansal Pharma

·         Cosmas Pharmacls

·         Divs Laboratories Limited

·         Dr. Reddy Laboratories Limited

·         Forgo Pharmaceuticals Private Limited

·         GMH Laboratories

·         Hitesh Sormulations private limited

·         Magbro Healthcare private limited

·         Shiva Traders

·         Theon Pharmaceuticals Private Limited

·         Unnati Pharmaceuticals Private Limited

·         Vardman Pharmachem 

 

 

Customers :

Wholesalers and Retailers

 

 

No. of Employees :

100 (Approximately)

 

 

Bankers :

·         Bank of India,

Sector 20, Panchkula-134108, Haryana, India

 

·         ICICI Bank

·         Citi Bank

·         HDFC Bank

·         State Bank of India

 

 

Facilities :

CC = Rs.18.500 Millions from Bank of India

 

Secured Loans

31.03.2011

31.03.2010

 

 

(Rs. In Millions)

 

 

 

Bank of India – CC671530110000005

(Secured against stock and debtors)

7.760

5.409

Bank of India – CC671530110000048

9.517

0.000

Bank of India – CC671530110000049

(Secured against Stock and Debtors)

3.876

0.000

Bank of India-T/L Building

4.372

1.987

Bank of India-T/L Machinery

10.183

8.537

 

 

 

Total

 

35.708

15.933

 

 

Unsecured Loans

31.03.2011

31.03.2010

 

 

(Rs. In Millions)

 

 

 

Reliance Capital Limited

1.268

2.010

ICICI Bank OD a/c

0.386

0.733

Citi Bank

0.000

0.020

Citi Bank Loan 2

0.000

0.595

HDC Bank Loan 2

0.000

0.380

Trade securities from Customer

1.655

1.655

 

 

 

Total

 

3.309

5.393

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Avnish Sharma and Associates

Chartered Accountant

Address :

SCO 47, Dakshin Marg, Sector 20-C, Chandigarh – 160020, India

Tel. No.:

91-172-2706330/ 5076330

PAN No.:

AABFA5610M

E-Mail :

avnish61@hotmail.com

avnishca@hotmail.com

 

 

CAPITAL STRUCTURE

 

(AS ON 30.09.2011)

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

250000

Equity Share

Rs.10/- each

Rs.2.500 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

89000

Equity Share

Rs.10/- each

Rs.0.890 Million

 

 

 

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2011

31.03.2010

31.03.2009

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

0.890

0.890

0.890

2] Share Application Money

0.650

0.650

0.650

3] Reserves & Surplus

7.139

4.825

4.233

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

8.679

6.365

5.773

LOAN FUNDS

 

 

 

1] Secured Loans

35.708

15.933

10.934

2] Unsecured Loans

3.309

5.393

3.839

TOTAL BORROWING

39.017

21.326

14.773

DEFERRED TAX LIABILITIES

0.717

0.547

0.000

 

 

 

 

TOTAL

48.413

28.238

20.546

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

43.797

33.639

0.944

Capital work-in-progress

0.000

9.460

27.437

 

 

 

 

INVESTMENT

0.000

0.000

0.000

DEFERREX TAX ASSETS

0.000

0.000

0.033

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

12.781
4.274
1.976

 

Sundry Debtors

0.000
0.000
6.276

 

Cash & Bank Balances

11.172
10.106
3.190

 

Other Current Assets

0.000

0.000

0.000

 

Loans & Advances

12.288
1.305
1.676

Total Current Assets

36.241
15.685
13.118

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditor

31.625
30.546
20.993

 

Other Current Liabilities

0.000

0.000

0.000

 

Provisions

0.000

0.000

0.000

Total Current Liabilities

31.625
30.546
20.993

Net Current Assets

4.616
(14.861)
(7.875)

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.007

 

 

 

 

TOTAL

48.413

28.238

20.546

 

 

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2011

31.03.2010

31.03.2009

 

SALES

 

 

 

 

 

Sales and Other Income

108.169

82.798

72.344

 

 

TOTAL                                     (A)

108.169

82.798

72.344

 

 

 

 

 

Less

EXPENSES

 

 

 

 

TOTAL                                     (B)

96.990

79.329

 

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

11.179

3.469

 

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

3.142

1.084

71.591

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

8.037

2.385

(Including Financial Expenses and Depreciation 

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

5.005

1.212

 

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                              (G)

3.032

1.173

0.753

 

 

 

 

 

Less

TAX                                                                  (H)

0.719

0.581

NA

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

2.313

0.592

NA

 

 

 

 

 

 

Earnings Per Share (Rs.)

25.99

6.65

--

 

 

Particulars

 

 

 

31.03.2012

Sales Turnover (Approximately)

 

 

150.00

 

 

 

 

 

Expected Sales (2012-13): Rs.200.000 Millions

 

The above information has been parted by Mr. Kuljender.

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

31.03.2009

PAT / Total Income

(%)

2.14

0.71

NA

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

3.79

2.38

5.35

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.35

0.18

NA

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

8.14

8.15

6.20

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.15

0.51

0.62

 


 

LOCAL AGENCY FURTHER INFORMATION

 

Check list by info Agents

Available in Report

(Yes/ No)

 

 

Year of Establishment

Yes

Locality of the Firm

Yes

Constitution of the Firm

Yes

Premises details

Yes

Type of Business

Yes

Line of Business 

Yes

Promoter’s Background 

Yes

No. of Employees

Yes

Name of Person Contacted

Yes

Designation of Contact person

Yes

Turnover of Firm for last three years

Yes

Profitability for last three years

Yes

Reasons for variation <> 20%

-----

Estimation for coming financial year

Yes

Capital in the business

Yes

Details of sister concerns

No

Major Suppliers

Yes

Major Customers

No

Payments Terms

Yes

Export/ Imports Details (If applicable)

Yes

Market Information

-----

Litigations that the firm/ Promoters Involved in

-----

Banking details

Yes

Banking Facility Details

Yes

Conduct of the Banking Account

-----

Buyer visit details

-----

Financials, if provided

Yes

Incorporation details is applicable

Yes

Last Accounts filed at ROC

Yes

Major Shareholders, if available

Yes

 

NOTE

 

The Registered office of the company has been shifted from 62, Industrial Area, Phase-II, Chandigarh, India to the present address w.e.f 30.06.2006.

 

 

FIXED ASSETS

 

·         Land

·         Building

·         Trade Marks

·         Air Conditioner

·         Strapping Machine

·         Refrigerator

·         Generator

·         Furniture and Fixture

·         Inventor, UPS and Mobile

·         Computer

·         Printer

·         Vacuum Cleaner

·         Fire Extinguisher

·         Car

·         Fire extinguisher

·         Photostats machine

·         Camera

·         Computer software

·         Lift

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.52.85

UK Pound

1

Rs.85.44

Euro

1

Rs.68.81

 

 

INFORMATION DETAILS

 

Information Gathered by :

SBA

 

 

Report Prepared by :

NIT

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

4

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

6

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

46

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

 

-

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.